Showing results (121-130 of 651) with videos related to

Sort By:
Pageof 66
BMC Medical Research Methodology|February 7, 2022
Statistical methods for evaluating the fine needle aspiration cytology procedure in breast cancer diagnosisCarolla El Chamieh, Philippe Vielh, Sylvie Chevret
Trials|February 22, 2016
Impact of the condolence letter on the experience of bereaved families after a death in intensive care: study protocol for a randomized controlled trialNancy Kentish-Barnes, Sylvie Chevret, Elie Azoulay
Critical Care (London, England)|August 5, 2025
Beyond the ventilator-free days: review of several estimandsLaurent Renard Triché, Matthieu Jabaudon, Sylvie Chevret
Antiviral Therapy|November 14, 2015
Efficacy and safety of a switch to rilpivirine-based regimens in treatment-experienced HIV-1-infected patients: a cohort studySandrine Gazaignes, Matthieu Resche-Rigon, Caroline Gatey, et al.
Clinical and Experimental Rheumatology|June 30, 2015
Long-term outcome of infliximab in severe chronic and refractory systemic sarcoidosis: a report of 16 casesCatherine Chapelon-Abric, David Saadoun, Lucie Biard, et al.
Melanoma Research|March 1, 2019
Checkpoint inhibitor treatment induces an increase in HbA1c in nondiabetic patientsMarie-Léa Gauci, Philippe Boudou, Pierre-Alexandre Squara, et al.
Melanoma Research|October 28, 2009
Interest in an original methodology to define the optimal dosage of interferon-alpha-2a in metastatic melanoma patientsSarah Zohar, Jacques Medioni, Céleste Lebbé, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 25, 2005
Comparison of digital and ultrasonographic examination of the cervix in predicting time interval from induction to delivery in women with a low Bishop scorePatrick Rozenberg, Sylvie Chevret, Claude Chastang, et al.
JCO Clinical Cancer Informatics|December 15, 2025
Detecting the Cure Model Appropriateness in Randomized Clinical Trials With Long-Term SurvivorsCheryl Kouadio, Subodh Selukar, Megan Othus, et al.
Statistics in Medicine|June 6, 2024
Two-stage randomized clinical trials with a right-censored endpoint: Comparison of frequentist and Bayesian adaptive designsLuana Boumendil, Sylvie Chevret, Vincent Lévy, et al.
Pageof 66